Drug intelligence / Profile preview

Sumenta

Development stage
Unknown
Lead developer
Charak
Administration
Oral
01

Overview

Sumenta is a proprietary Ayurvedic herbal formulation developed and manufactured by Charak Pharma for the management of mild to moderate clinical anxiety, depression, and stress. It is a mixture of several traditional adaptogenic, anxiolytic, and neuroprotective herbs, including Brahmi (*Bacopa monnieri*), Ashwagandha (*Withania somnifera*), Jatamansi (*Nardostachys jatamansi*), and Tagar (*Valeriana wallichii*). Sumenta is designed to help relax the nervous system, stabilize mood, and promote restful sleep without causing drowsiness or dependency.

Brand names
Sumenta
Other names
Sumenta TabletSumenta Tablets

Beyond the preview

Go deeper on Sumenta.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sumenta.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call